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We identified a new protein containing the pleckstrin homology (PH) domain through tyrosine phosphoproteomics using epidermal growth
factor-stimulated cells. The tandem PH domains of this protein can bind to mitochondria-specific phospholipid, cardiolipin or its dehydro product,
phosphatidic acid; therefore, we have designated this protein as cardiolipin and phosphatidic acid-binding protein (CLPABP). In this study, we
show that CLPABP is localized on the tubulin network and the mitochondrial surface in the granular form along with other proteins and RNA. The
affinity of CLPABP to mitochondria is elevated depending on the extent of tyrosine phosphorylation. The CLPABP complex contains various
proteins related to cytoplasmic mRNA metabolism. The unique subcellular localization of CLPABP requires its PH domains and a multifunctional
protein, SF2p32, as its binding protein. The CLPABP granule also contains the cytochrome c transcript, which may be mediated by the RNA-
binding protein HuR. Immunofluorescence staining reveals that the CLPABP granule is colocalized with cytochrome c and various ribosomal
proteins that are present in the CLPABP complex. Therefore, the CLPABP RNA–protein complex may play a role in transporting cytochrome c
mRNA and its translated product to the mitochondria.
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In eukaryotic cells, after the introns are excluded, the pro-
cessed mRNA is translocated from the nucleus to the cytoplasm
[1–4]. To complete this process, a large functional protein
complex termed the spliceosome associates itself with the
mRNA in the nucleus [5,6], and some of its components such as
serine/arginine-rich (SR)-family proteins are exported to the
cytoplasm along with the mRNA [7]. Other SR-family proteins
are separated from the mRNA and imported into the nucleus.
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doi:10.1016/j.bbamcr.2007.12.009these proteins by SR-protein kinase (SRPK) [8,9]. Cytoplasmic
mRNA is known to exist along with various proteins that
function in controlling translation and degradation, which is
important for the regulation of eukaryotic gene expression [10].
These protein–mRNA complexes are probably localized in the
granular form at certain foci in mammalian cells and are known
as RNA granules [11]. Major RNA granules, including the stress
granule [12] and the processing body (P-body) [13,14] in the
somatic cells and the neuronal granule in neurons [15], are
classified based on their protein components and functions [11].
Various proteins in each RNA granule, such as ribosomal sub-
units, translation factors, decay enzymes, helicases, scaffold
proteins, and RNA-binding proteins, have been identified and
are categorized as either independent or overlapping factors
[11,16]. Although the independent function of each RNA
granule remains debated, all the RNA granules can repress
mRNA translation by suppressing their protein components
[11,13]. On the whole, the regulation of each mRNA in
Fig. 1. Primary structure, expression, and subcellular localization of CLPABP. (A) Schematic representation of the primary structure of CLPABP. The number of amino
acid residues on the boundaries is indicated. The locations of the two PH domains are indicated as PH1 and PH2. (B) CLPABP mRNA expression in various human
tissues (left) and cultured cells (right). Quantitative PCRwas performed; the amplified DNA fragments of the expected size (355 bp) derived from CLPABP cDNAs are
indicated by arrows in the upper panel. G3PDH was used as a loading control (lower panels). The number of PCR cycles for all the samples was 30. (C) Detection of
CLPABP by immunoblotting using a CLPABP-specific antibody (right panel) and preimmune rabbit serum (left panel). The WCL of HEK293 cells (left), COS-7 cells
transfected with the expression vector for pcDNA3-CLPABP (center), and N-terminal FLAG-tagged CLPABP (right) were used. Immunoblotting analysis was carried
out using an anti (α)-CLPABP antibody. The positions of the protein are indicated by arrows. (D) Induction of CLPABP expression in T-REX™-293 cells by adding
DOX. A comparison of the expression levels of CLPABP (upper panel) with (right) or without (left) DOX treatment for 24 h and the expression levels of β-tubulin in
each cell line as a control are shown (lower panel). (E) Endogenous CLPABP is localized on the microtubule in HeLa cells. The subcellular localization of CLPABPwas
traced by immunofluorescence using anti-CLPABP (a and d) and anti-β-tubulin antibodies (b and e); the nucleus was stained with Hechest33342 (b and e), and the
merged images are shown (c and f). The magnified images in the white box (c) are shown (d–f). The scale bars represent 10 µm.
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translation—is a complicated process. Recently, we analyzed
novel molecules that were identified through tyrosine phospho-
proteomics upon epidermal-growth-factor (EGF) stimulation,and we reported two molecules as the novel regulators of EGF-
receptor homeostasis [17,18]. In this report, we analyzed another
molecule containing two pleckstrin homology (PH) domains and
discovered that this protein functions in the mitochondrial RNA
1038 E. Sano et al. / Biochimica et Biophysica Acta 1783 (2008) 1036–1047granule. In mammalian cells, it is localized as a granule-like
structure on the mitochondrial surface and is stabilized by its
association with tubulin. The RNA granule assumes various
shapes and sizes while attached to the mitochondrial surface, and
some of its vesicles merge with cytochrome c. Both the PH
domains of this protein can bind to mitochondria-specific
phospholipids, cardiolipin (CL) or its dehydro product, phos-
phatidic acid (PA); therefore, we designated this protein as
CLPABP (CL-and PA-binding protein).
The CLPABP complex includes various proteins related to
mRNA metabolism, such as SR-family, ribosome-subunit,
RNA-binding, and RNA-stabilizing proteins. Furthermore, it
contains cytochrome cmRNA.Our results suggest that CLPABP
may conform to the mitochondrial RNA granule for carrying
mRNA of some mitochondrial proteins for facilitating its
recruitment.
2. Materials and methods
2.1. Cell culture and transfection
COS-7, HeLa, HEK293, 293T, and T-REX™-293 (Invitrogen) cells were
maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 100 µg/ml streptomycin, and 100 U/mlFig. 2. CLPABP is localized on the mitochondria, and its distribution is altered in resp
traced by immunofluorescence staining with the anti-CLPABP antibody (green); mi
stained with Hechest33342 (blue). The scale bars represent 10 µ m. (A) The accumula
cells were not treated (upper panel) or treated with (middle and lower panels) 0.5 mMH
(B) Biochemical analysis of the subcellular distribution of endogenous CLPABP. HeLa
(TCL), the cytosolic (Cyto. fr) andmitochondrial (Mito. fr) fractions of each cell line (2
using the indicated antibodies.penicillin. Plasmid transfection into COS-7 or 293T cells was carried out by
electroporation usingGene-Pulser (Bio-Rad). To establish a stable T-REX™-293
cell line, transfection was carried out using Lipofectamine 2000 (Invitrogen).
Prior to EGF stimulation, the cells were serum-starved for 16 h, and 100 ng/ml
EGF (Sigma) dissolved in a serum-free medium was added. Alternatively, the
cultured cells were treated with 0.5 mM H2O2.
2.2. cDNA cloning and vector construction
CLPABP cDNAwas purchased from the RZPDGerman Resource Center for
Genome Research. To clone this cDNA into an expression vector, polymerase
chain reaction (PCR) was performed using 2 primers—(5′-GTTTAAGCT-
TATGGGGAACAGCCACTGTGTC-3′ and 5′-GAAAGAATTCTCAGA-
TCCACTGCACAAGCCC-3′), which were designed based on the sequences
(gi|14149786) provided in the NCBI database. The amplified products were first
subcloned into a TOPO™ TA cloning vector, namely, pCR®2.1-TOPO (Invitro-
gen), and subsequently sequenced. The CLPABP cDNA was inserted into a
pcDNA3 vector (Stratagene) or into the in-frame expression vector pCMV-
FLAG6a (Sigma), and the constructswere expressed as non-tagged orN-terminal
FLAG-tagged proteins, respectively. The CLPABP cDNA deletion mutants were
generated by digesting the cDNAwith suitable restriction enzymes, followed by
PCR amplification, and the constructs were subcloned into a pCMV-FLAG6-
series vector. Point mutations or deletions were introduced by using the Quick-
Change kit (Stratagene) according to the manufacturer's protocol. All the nu-
cleotide sequences were determined and verified using an ABI prism dye
terminator cycle sequencing kit (PerkinElmer Life Sciences) and an ABI Prism
3100-Avant genetic analyzer.onse to cellular stimuli. The subcellular localization of endogenous CLPABP was
tochondria were stained with the anti-SF2p32 antibody (red). The nucleus was
tion of endogenous CLPABP in the mitochondria due to oxidative stress. COS-7
2O2 for 90min. An image of a typical apoptotic cell is shown in the lower panels.
cells were treated with either EGF or H2O2. The proteins from the total cell lysate
0 µg each) were used as indicated, and immunoblotting analyses were carried out
Fig. 3. Identification of CLPABP-binding proteins. (A) The purification of the CLPABP complex. FLAG-CLPABP was purified from HEK293T cells transfected with
the expression plasmid (right lane). As a control, mock-transfected HEK293Tcells transfected with the empty vector were used (left lane). The affinity-purified protein
eluted using the FLAG peptide was analyzed by SDS-PAGE. All the visible bands indicated by numbers were subjected to in-gel digestion, and the peptides were
analyzed by LC/MS/MS. (B) The names of proteins identified from the numbered gel pieces (A) and their gene identification (gi) numbers are indicated. The existence
of boxed molecules in the complex was confirmed by immunoblotting in Fig. 4.
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An anti-CLPABP rabbit polyclonal antibody was raised against a CLPABP
fragment containing residues 500–611, which was bacterially produced as a gluta-
thione S-transferase (GST) fusion protein by using the pGEX4T vector (Amersham
Biosciences). This antibody was purified by using HiTrap N-hydroxysuccinimide-
activated sepharose columns (AmershamBiosciences) coupledwith an immunizing
antigen. An anti-IMP rabbit polyclonal antibody was raised against a 15-amino
acid peptide corresponding to the C-terminal of the protein. The following other
antibodies were obtained commercially from various companies: anti-FLAG M2,
anti-β-actin, and anti-β-tubulin (Sigma); anti-phosphotyrosine (4G10, Up-
state Biotech Inc.); anti-SF2p32, anti-14-3-3ɛ, anti-cytochrome c, anti-SAP145,
anti-hnRNPM3/4, anti-Y-box, anti-ASF/SF2, anti-COX4, and anti-HuR (sc-23885,
sc-17784, sc-7159, sc-14279, sc-20001, sc-18057, sc-28724, sc-20694, sc-58348,
and sc-5261, respectively; Santa Cruz Biotechnology); anti-GST (MBL); anti-myc
(9E10, Roche); anti-paxillin, anti-GRP78, anti-GM130, anti-Bcl-2 and anti-Hsp70
(BD Transduction); anti-G3BP (Abcam); anti-VDAC1 (Calbiochem); and anti-
Staufen (Chemicon).
2.4. Semiquantitative reverse transcriptase (RT)-PCR
To assess the relative expression levels of the CLPABP transcripts, RT-PCR
was performed on each panel of eight different human culture cell and tissue
cDNAs (human tissue and cell line MTC panel, Clontech) by using the primers
5′-GTTTGGATCCTCTGTGCCTGCCTCTGACCCT-3′ and 5′-GAAA-
GAATTCTCAGATCCACTGCACAAGCCC-3′. The normalized cDNA was
amplified under the following conditions: denaturation at 94 °C for 1 min;
30 cycles at 94 °C for 30 s, 55 °C for 30 s, and 72 °C for 1 min; and extension at
72 °C for 5 min. The PCR products were electrophoresed on 1.5% agarose gels
containing ethidium bromide.2.5. Cloning of the T-REX™-293 stable cell line
Full-length CLPABP cDNAwas inserted into a pcDNA4 vector (Invitrogen).
T-REX™-293 cells were then transfected with either the empty vector or the
resulting hybrid. Zeocin™-resistant cells were isolated in the presence of 0.1 mg/
ml Zeocin™ (Invitrogen) and cloned. The CLPABP expression was induced by
the addition of 1 µg/ml doxycycline (DOX) (Clontech) in the medium.
2.6. Small interference RNA (siRNA)
Synthetic siRNA duplexes were used for the knockdown of CLPABP expres-
sion in the HeLa cells. The targeted human CLPABP sequence was 5′-AAGGA-
GAAGCAGATCCGCTCCTT-3′ (nucleotides 832–854). The siRNA for green
fluorescence protein (GFP) was used as a control. The HeLa cells were transfected
with siRNA by using oligofectamine (Invitrogen).
2.7. Immunoprecipitation and immunoblot analysis
The following procedures were carried out at 0–4 °C. The transfected cells
were lysed in a lysis buffer containing 20 mM Tris–HCl (pH 7.5), 1 mM EDTA,
10 mMDTT, 1% Triton X-100, 150 mMNaCl, 10 mMNaF, 1 mMNa3VO4, and
a complete protease inhibitor cocktail (Roche) to produce a whole-cell lysate
(WCL). For the immunoprecipitation experiments, the WCL was centrifuged,
and the supernatant was incubated for 2 h with either the primary antibody or an
anti-FLAG affinity gel (Sigma). Protein G-Sepharose (Amersham Biosciences)
was added, and the resulting mixture was rotated at 4 °C for 1 h. The beads were
subsequently washed three times with the lysis buffer. The processed samples
were boiled in sodium dodecyl sulfate (SDS) sample buffer, separated by SDS-
polyacrylamide gel electrophoresis (PAGE), and transferred onto an Immobilon-
P membrane (Millipore). Immunoblot analysis was carried out using primary
Fig. 4. Purification of CLPABP complex with or without RNase treatment. (A) In this assay, 10 µg/ml of RNase was added to the lysate prior to the purification step (lane 3).
Each purified CLPABP complex was visualized as shown in Fig. 3. (B) The binding of FLAG-CLPABP to the indicated proteins was confirmed by immunoblotting. The
WCLofHEK293Tcells expressing FLAG-CLPABPwas applied to lane 1.Coimmunoprecipitation studies were carried outwith the anti-FLAGantibody using the lysates of
HEK293T cells transfected with the empty vector (lane 2) or the FLAG-CLPABP expression plasmid (lane 3, 4). The WCL was treated with RNase A (10 µg/ml) prior to
immunoprecipitation (lane 3). Immunoblot analysis was carried out using the anti-CLPABP antibody (bottom panel) or the indicated antibodies. (C) Association between
endogenous CLPABP and SF2p32 in vivo. Coimmunoprecipitation experiments were carried out with control IgG and anti-CLPABP antibodies using the HeLa cell lysates.
Immunoblot analysis was carried out using anti-CLPABP (upper panel) and anti-SF2p32 antibodies (lower panel). (D) Reciprocal coimmunoprecipitation studies were
carried out using the HeLa cell lysates. (E) Subcellular localization of GFP-CLPABP. COS-7 cells were transfected with the expression vector encoding GFP-CLPABP (a).
The cells were processed for coimmunofluorescence staining 36 h after transfection using the anti-cytochrome c (b) and anti-β-tubulin antibodies (c). Merged images of the
panels are shown (panel d). The magnified images in the white box (E) are shown in four panels below. (F) Partial colocalization of CLPABP in the ER.
Coimmunofluorescence stainingwas performed as that in (E). The ERwas stainedwith ER-Tracker dye (middle).Merged images of the panels are shown in the bottompanel.
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visualized using horseradish peroxidase (HRP)-conjugated anti-rabbit or anti-
mouse IgG and ECL reagent (Amersham Biosciences).
2.8. Purification of FLAG-CLPABP and its binding proteins
Then, 293T cells (1×108 cells) transiently expressing FLAG-tagged
CLPABP were lysed with the lysis buffer. The lysate was centrifuged, and the
supernatant was incubated with a FLAG-affinity gel (bed volume: 50 µl) for
2 h. The gel was applied to an empty mini column (Bio-Rad) and washed
several times with the lysis buffer. FLAG-CLPABP was eluted with the FLAG
peptide and resolved by performing SDS-PAGE. All the bands that were
visualized by Coomassie brilliant blue (CBB) staining were subjected to mass
spectrometry (MS/MS) analysis following in-gel digestion with trypsin. The
in-gel digestion and mass spectrometric analysis were performed as described
previously [19].
2.9. Lipid-binding assay
Membrane lipid strips spotted with 15 different lipids were obtained from
Echelon Biosciences Inc. The strips were blocked with 3% fatty-acid-free
bovine serum albumin in Tris-buffered saline with 0.1% Tween 20 (TBS-T;
20 mM Tris (pH 8.0), 150 mM NaCl, and 0.1% Tween 20) and incubated with
GST-fused protein (0.5 µg/ml) for 3 h. After washing, the membranes were
incubated with an anti-GST antibody for 2 h, followed by additional washing
and incubation with an HRP-conjugated antibody. After the final washing, lipid-
bound GST-fusion proteins were detected by ECL.
2.10. Fluorescence and confocal microscopy analysis
To express GFP-fused CLPABP in the cultured cells, the full-length
CLPABP cDNA was inserted into a pEGFP-C3 vector (Clontech) in frame.
Transfected and nontransfected cells were fixed with 5% formaldehyde in PBS
for 10 min, washed with PBS, permeabilized with 0.1% Triton X-100 in PBS for
10 min, and washed with PBS once again. Following a blocking step with 3%
bovine serum albumin in PBS for 30 min, the primary antibodies, as illustrated
in the figures, were applied for 1 h. After washing with PBS, the cells were
incubated with the appropriate secondary antibodies conjugated with Alexa
fluorescent dyes (Molecular Probes) for 45 min. If necessary, the cells were
treated with Mito-or ER-Tracker (Molecular Probes), and the nuclei were
simultaneously stained with 2 µM Hoechst 33342 (Molecular Probes). Finally,
the cells were rinsed three times with PBS and mounted onto microscope slides
with ProLong Antifade reagents (Molecular Probes). Images were captured
using a Zeiss Axiovert 200 fluorescence microscope or an LSM 510 Meta laser
scanning confocal microscope with a 40, 63, and 100×1.0 numerical aperture
PlanApo objective (Zeiss Axioskop, Carl Zeiss Inc.). The figures were prepared
using Adobe Photoshop.
2.11. Preparation of mitochondrial fraction
For CLPABP and cytochrome c redistribution studies, the mitochondrial
fraction was prepared from HeLa cells with or without cellular stimulation, as
described previously [20].
2.12. Detection of apoptotic cells
Apoptotic cells were quantified by counting the COS-7 cells that expressed
GFP or GFP-CLPABP under a fluorescence microscope following Annexin V-
Alexa594 (Molecular Probes) staining. More than approximately 100 GFP-
positive cells were counted. Three independent sets of experiments were carried
out. The error bars show the standard deviation.2.13. RNA preparation
RNA was extracted from the immunoprecipitated CLPABP complex with
either the anti-FLAG or anti-CLPABP antibody using the Trizol reagent, asinstructed by the manufacturer (Invitrogen). The following primers were used for
RT-PCR of the cytochrome c (full-length) and G3PDH transcripts: cytochrome c,
5′-GTTTAAGCTTTGGGTGATGTTGAGAAA-3′ and 5′-TGAAGGTCG-
GAGTCAACGGATTTGGT-3′, and G3PDH, 5′-TGAAGGTCGGAGT-
CAACGGATTTGGT-3′ and 5′-CATGTGGGCCATGAGGTCCACCAC-3′.3. Results
3.1. Primary structure, expression, and subcellular localization
of CLPABP
Previously, we identified more than 150 proteins through
phosphoproteomic studies using the lysate of EGF-stimulated
A431 cells [17,18]. In the present study, we focused on a newly
identified molecule, CLPABP, that contains two PH domains in
its N-terminal half, as shown in Fig. 1A. The CLPABP protein
comprises 611 amino acid residues, and its cDNA has been
cloned in human full-length cDNA sequencing projects in
Germany and has been stored as DKFZP434H2010 (gi|
14149786). According to the genome database, the homologous
genes of human CLPABP have been cloned from zebra fish,
frog, and several species of mammals but not from worms and
fly species. Semiquantitative RT-PCR confirmed that the
CLPABP gene expression is essentially ubiquitous in human
tissues and cultured cells (Fig. 1B). The specific antibody
produced by immunizing the GST-fused C-terminal region of
CLPABP was effective for the detection of endogenous and
exogenous CLPABP in the WCL analysis, whereas preimmune
serum was not (Fig. 1C). Furthermore, we established cell lines
that inducibly expressed exogenous CLPABP: using this
specific antibody, we determined whether CLPABP expression
in the WCL was elevated due to the DOX treatment or not
(Fig. 1D). The PH domain is well established as a lipid-binding
domain, and various proteins related to growth factor receptor-
mediated signal transduction possess this functional domain for
their localization at the plasma membrane. However, immuno-
fluorescence microscopy of HeLa cells revealed that CLPABP
was subcellularly localized on the microtubule in the form of
small granules (Fig. 1E).
3.2. CLPABP is localized on mitochondria
The recruitment of a PH-domain-containing protein to the
plasma membrane is dependent on cellular stimuli such as
treatment with growth factors [21]. Therefore, we observed the
subcellular distribution of CLPABP in response to EGF
treatment and oxidative stress. CLPABP was not translocated
to the plasma membrane following these stimulations; however,
it accumulated on the mitochondria (Fig. 2A). Biochemical
observations revealed that CLPABP was included in the
mitochondrial fraction, and small amounts of CLPABP in the
cytosolic fraction (but not in the mitochondrial fraction) were
reduced with EGF stimulation and oxidative stress (Fig. 2B).
These results suggest that the localization and function of
CLPABP might differ from those of typical PH-domain-
containing proteins that play a role as downstream molecules
for the EGF receptor.
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To gain insights into the functions of CLPABP, we analyzed
the proteins that coprecipitated with it by performing immu-
noaffinity purification. HEK293T cells transfected with the
expression plasmid for FLAG-tagged CLPABP were lysed with
buffer containing 1% Triton X-100, and immunoprecipitation
was carried out using an anti-FLAG affinity gel. Proteins eluted
along with the FLAG peptide were analyzed by SDS-PAGE
(Fig. 3A). In addition to CLPABP, other observed protein bandswere also analyzed by tandem mass spectrometry (LC/MS/MS)
in order to identify their amino acid sequences. The identified
proteins were almost related to RNA processing (Fig. 3B), and
representative proteins could be confirmed by their existences
in the FLAG-CLPABP complex with or without RNase
treatment (Fig. 4A, B). Although many proteins were associated
with FLAG-CLPABP, SF2Ap32 (also known as a p32 mito-
chondrial matrix protein, hyaluronan-binding protein, or gC1Q-
R) may play a central role in the mitochondrial localization of
CLPABP. In addition to SF2Ap32, ASF/SF2 was also included
1043E. Sano et al. / Biochimica et Biophysica Acta 1783 (2008) 1036–1047in the CLPABP complex; the regulation of the ternary complex
comprising these three proteins depended on the presence of
RNA (Fig. 4B). The association of SF2Ap32 with CLPABP in
HeLa cells was further confirmed by an immunoprecipitation
assay using specific antibodies. Endogenous SF2Ap32 was
detected in the immune complex that was precipitated by using
the anti-CLPABP antibody. These results were confirmed by
reciprocal immunoprecipitation experiments performed using
the anti-SF2Ap32 antibody (Fig. 4C, D). It is well known that
mitochondrial morphology and distribution were coordinated
with a tubulin cytoskeleton [22]. Consistent with the biochem-
ical results suggesting the presence of α-tubulin in the CLPABP
complex, GFP-fused CLPABP was colocalized not only on
tubular mitochondria but also on the small cytochrome c gra-
nules contained in the tubulin network (Fig. 4E). Other orga-
nelle markers (golgi, early endosomes, and lysosomes) were not
merged with the vesicles (data not shown). However, some of
the granules were localized close to the endoplasmic reticulum
(ER) (Fig. 4F).
3.4. Detection of CLPABP domains essential for its binding
with other proteins
To analyze the binding mechanisms of CLPABP and
SF2p32 in detail, several constructs were expressed in COS-7
cells, and the interaction was assessed by immunoprecipitation
(Fig. 5A). The obtained results revealed that the N-terminal
region (amino acid residues: 61–100) of CLPABP is required
for its binding to endogenous SF2p32. Moreover, its binding
affinity is upregulated when the tyrosine phosphorylation of
CLPABP is induced by oxidative stress (Fig. 5B). Next, we
constructed truncated mutants (data not shown) and several
point mutants of CLPABP that were replaced at potentially
phosphorylated tyrosine residues (Y) by phenylalanine (F). A
double mutant of Y305/456F almost abolished the tyrosine
phosphorylation upon H2O2 stimulation. Furthermore, this
mutant was hardly bound to SF2p32 (Fig. 5B). Therefore, the
interaction of these proteins may be regulated by the phospho-
rylation of the two tyrosine residues (Y305 and Y456) of
CLPABP.
The two PH domains are the most typical functional regions
in CLPABP. The PH domain is known as a lipid-binding domain
that functions in the recruitment of the protein to the plasmaFig. 5. Identification of the SF2p32-binding site in CLPABP, and the roles of its PH
precipitation studieswere carried out with the anti-FLAG antibody using the lysates of C
CLPABP derivatives. The number of amino acid residues of each derivative is shown
anti-SF2p32 antibodies (lower panel). (B) Effects of tyrosine phosphorylation of CLPA
studies were carried out with the anti-FLAG antibody using the lysates of COS-7 cells
derivatives that replaced tyrosine residues (Y) by phenyl alanine (F) were treated wi
are tyrosine residues IB analysis as carried out using the anti-FLAG (upper panel), ant
the lipids bound to the PH domains of CLPABP. (a) Nitrocellulose strips spotted w
4, phosphatidylserine; 5, phosphatidylethanolamine; 6, phosphatidylcholine; 7, pho
12, PtdIns(3,4,5)P3; 13, cholesterol; 14, sphingomyelin; 15, 3-sulfogalactosylceramid
stained with CBB, as shown in (b). The strip was incubated with GST (c), GST-PLCγ
using the anti-GST antibody. Bound lipids are indicated by arrows and numbers. (D)
transfected with the expression vector encoding FLAG-CLPABP derivatives. The cel
using anti-FLAG (green) and anti-cytochrome c (red) antibodies. The merged imagemembrane or the surface of some organelles related to
endocytosis [21]. To screen the lipids that are bound to the PH
domain of CLPABP, we performed an overlay assay using GST-
fused PH domains (PH1 and PH2) as a bait (Fig. 5C(b)) and
membrane lipid strips (Fig. 5C(a)). GSTwas not bound to any of
the spotted lipids, and a positive control of the GST-PH domain
derived from PLCγ recognized phosphatidylinositol 4,5-dipho-
sphates (PI 4,5-P2) (Fig. 5C(c, d)). However, the mitochondria-
specific lipid, CL and its hydrolysis product, PA formed by
phospholipase D (PLD) were observed to bind both the PH
domains (Fig. 5C(e, f)). In addition, phosphatidylserine (PS) and
PI4-P could bind to the C-terminal PH domain (PH2) (Fig. 5C
(f)). These results suggest that the N-terminal region of CLPABP
containing the PH domains may be necessary for its unique
subcellular localization. Therefore, we analyzed the localization
of each CLPABP derivative in the cells (Fig. 5D). The two
truncated mutants containing amino acid residues 1–450 and
61–611 resembled the wild-type CLPABP. The mutants lacked
the SF2Ap32 binding site (101–611), and the first PH domain
(181–611) still exhibited the vesicular form around the
mitochondria; however, the intensity of the immunoreactive
signal in the cytosolic fraction increased dramatically (data not
shown). Vesicle formation and mitochondrial localization was
abolished in the shortest mutant containing amino acid residues
251–611 and lacking the N-terminal region of PH2 and in a
double mutant of Y305/456F. Therefore, we conclude that the
SF2Ap32-binding site and two PH domains of CLPABP are
essential for its unique localization in cells, which is regulated by
tyrosine phosphorylation.
3.5. Function of CLPABP as cargo protein for cytochrome c
mRNA
To effectively analyze the functions of CLPABP, we at-
tempted to establish a stable cell line overexpressing this protein.
The cell lines obtained by using a constitutively active promoter
did not express recombinant CLPABP for cell toxicity. Alter-
natively, T-REX™-293 cell lines obtained on using a tetracy-
cline-inducible promoter expressed high amounts of CLPABP
when a tetracycline analogue DOX was added. After induction
of the CLPABP expression, a large number of CLPABP granules
were detected in the cells (Fig. 6A). Next, we attempted to obtain
RNA from the immune complex formed with the CLPABPdomains. (A) Binding of FLAG-CLPABP to endogenous SF2p32. Coimmuno-
OS-7 cells transfectedwith the empty vector or the expression plasmid of FLAG-
. Immunoblotting analysis was carried out using the anti-FLAG (upper panel) or
BP induced by oxidative stress on its binding to SF2p32. Coimmunoprecipitation
transfected with the empty vector or the expression plasmid of FLAG-CLPABP
th (+) or without (−) 0.5 mM H2O2 for 30 min. The number of each derivative
i-pY (middle panel), or anti-SF2p32 antibody (lower panel). (C) The screening of
ith the lipids as follows: 1, triglyceride; 2, diacylgycerol; 3, phosphatidic acid;
sphatidylglycerol; 8, cardiolipin; 9, PtdIns; 10, PtdIns(4)P; 11, PtdIns(4,5)P2;
e; and 16, solvent blank. Purified GST-PH1, 2 of CLPABP and control GSTwere
-PH (d), GST-PH1 (e), or GST-PH2 (f). The signal was detected by overlay assay
The domain effects of CLPABP on its subcellular localization. COS-7 cells were
ls were processed for coimmunofluorescence staining, 36 h after the transfection
of the panels is shown in the right panel. The scale bars represent 10 µm.
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CLPABP expression was induced but also from the control cells
that expressed the protein at an endogenous level (Fig. 6B). We
investigated a crucial factor according to which mRNA
transcripts were included in the CLPABP complex. Recently,
an RNA-binding protein, HuR, has been identified to function as
a translational regulatory factor of cytochrome c by binding tothe 3′-UTR sequence of its mRNA [23]. Since HuR is one of the
factors associated with the CLPABP complex, endogenous HuR
and CLPABP interacted within the cells (Fig. 6C). Thus, we
attempted to detect cytochrome c mRNA in the CLPABP
complex by performing RT-PCR. Expectedly, the mRNA of
cytochrome c (but not of G3PDH) was amplified from the RNA
extracted from the CLPABP complex (Fig. 6D). Furthermore,
1045E. Sano et al. / Biochimica et Biophysica Acta 1783 (2008) 1036–1047the protein expression levels of cytochrome c were elevated in
the cells overexpressing CLPABP (Fig. 6E). On the other hand,
in cells where the CLPABP expression was suppressed by RNA
interference, the cytochrome c level was decreased (Fig. 6F) and
mitochondrial defects were observed (Fig. 6G). Therefore,
CLPABP might play a role in the general maintenance of
mitochondria to sustain the expression level of cytochrome c in
the cells. The CLPABP complex contained many ribosomal
proteins. Therefore, it is possible that cytochrome c translation
may have occurred. The fluorescence microscopy analyses
revealed that the cytoplasmic small dot signals of cytochrome c
existed at the same location as that of GFP-CLPABP; this
prompted us to investigate the relationship between CLPABP
and the apoptosome of apoptotic cells. The COS-7 cells that
expressed recombinant CLPABP but not the N-terminal deletion
mutant exhibited an apoptotic morphology (Fig. 6H, I). There-
fore, we analyzed the relationship between CLPABP andApaf-1,
one of the central components of the apoptosome [24]. Apaf-1
was diffusively localized in the cytosol of normal cells; however,
two days after transfection, it aggregated in the vesicle of GFP-
CLPABP (Fig. 6J). We demonstrated that small cytochrome c
granules were present in the CLPABP vesicle (Fig. 3D). There-
fore, translated cytochrome c may be associated with Apaf-1 in
the CLPABP complex.
4. Discussion
In the present study, we demonstrated that CLPABP is
localized on the microtubule and mitochondria as a large
protein-RNA complex. CLPABP accumulates in the mitochon-
dria in the granular form; this unique subcellular localization
occurs via phosphorylation of its tyrosine residues in response
to EGF stimulation or oxidative stress. We identified certain
CLPABP-binding proteins; among these, SF2Ap32 may be
important for the recruitment of CLPABP into the mitochondria.
However, SF2Ap32 has not been analyzed in detail with regard
to its mitochondrial function. Although SF2Ap32 has recently
been identified as a mitochondrial matrix protein, it was origi-
nally identified as a protein that binds and regulates ASF/SF2,
a member of the SR-protein family [25,26]. The binding of
ASF/SF2 to RNA is known to be controlled by its phosphor-Fig. 6. CLPABP complex as RNA granules. (A) Induction of CLPABP expr
coimmunofluorescence staining for two days with (lower) or without (upper) DOX
(B) The CLPABP complex containing RNA. The extraction of RNA from the immun
Immunoprecipitation was performed using the WCL of the untreated (lane 2) and DO
Coimmunoprecipitation experiments were carried out with control IgG and anti-HuR
using anti-CLPABP (upper panel) and anti-HuR antibodies (lower panel). (D) The fu
was carried out using primers for cytochrome c (three left lanes) or G3PDH (lane to th
numbers are comparable to (B). (E) Comparison of the expression levels of CLPABP
lane) DOX treatment for 48 h; the expression levels of β-actin in each cell line are sho
in HeLa cells. Immunoblot analyses were carried out using the indicated antibodie
(G) Effect of siRNA-induced suppression of CLPABP expression on the mitoch
Representative cell images of staining with the anti-CLPABP antibody (upper pa
expression are indicated by arrows. The scale bars represent 10 µm. (H) Effect of CL
GFP-CLPABP overexpression 60 h after transfection. The GFP-CLPABP images a
nucleus. (I) Graph showing the percentage of apoptosis induced by expressing G
localization of GFP-CLPABP and endogenous Apaf-1. COS-7 cells were transfected
for coimmunofluorescence staining at 48 h after transfection using anti-Apaf-1 (b); H
shown (d). The scale bars represent 10 µm.ylation and association with SF2Ap32 [7,8,27]. In addition to
SF2Ap32, ASF/SF2, other SR proteins, Srp20, and SRPK, a
specific kinase [28] for SR proteins, were also included in the
CLPABP complex. SR proteins play roles as export adaptors of
mRNA, mediators of mRNA stability, and regulators of mRNA
translation [26]. Thus, these events may have occurred in the
CLPABP complex.
Our CLPABP-deletion analysis revealed that SF2Ap32
binding is indispensable for the unique localization of CLPABP
on the surface of mitochondria; the 40 amino acid N-terminal
region of CLPABP, which has no similarity with other proteins,
plays a crucial role in the binding of CLPABP to SF2Ap32 (Fig.
3A, B). Furthermore, the interaction between SF2Ap32 and
CLPABP is regulated by the tyrosine phosphorylation of
CLPABP induced by oxidative stress.
Although various types of PH domains have been studied
with regard to their wide range of lipid specificities [21], the PH
domains of CLPABP possess a unique ability to bind to CL, PA,
PS, and PI4-P (Fig. 4D). The PH domain of Cool/βPix that
functions downstream in growth factor receptor signaling
exhibits a slight similarity to the PH domains of CLPABP
[29]. However, Cool/βPix is not reported to be localized on the
mitochondria. To construct an effector mutant for further
functional studies on CLPABP in the future, mutational and
structural analyses based on the information involving other PH
domains is required.
We hypothesized the mechanism by which CL and
SF2Ap32, which are typically lodged within the mitochondria,
come in contact with CLPABP. Data obtained from recent
studies on CL metabolism may provide some insights into this
mechanism [30–32]. The negatively charged lipid CL is mainly
present in the inner membrane of the mitochondria. However,
CL has been shown to translocate from the inner membrane to
the outer membrane and is also known to leak outward from the
mitochondria during apoptosis [33]. Most recently, it has been
reported that the hydrolysis of CL to PA in the outer leaflet
of the outer mitochondrial membrane by PLD plays a crucial
role in mitochondrial fusion [34]. Frequently, the mitochondria
are morphologically altered by fission and fusion [35]; there-
fore, it is possible that less-abundant CL is normally localized
on the mitochondrial surface. Thus, CLPABP may recognizeession in T-REX™-293 cells by adding DOX. Cells were processed for
treatment by using the anti-CLPABP antibody. The scale bars represent 10 µm.
oprecipitants using control IgG (lane 1) or the anti-CLPABP antibody (lane 2, 3).
X-treated cells. (C) Association between endogenous CLPABP and HuR in vivo.
antibodies using the indicated cell lysates. Immunoblot analysis was carried out
ll-length mRNA of cytochrome c is present in the CLPABP complex. RT-PCR
e extreme right). The purified RNA in (B) was used as a template, and the sample
(upper panel) and cytochrome c (lower panel) with (right lane) or without (left
wn as a control (middle lane). (F) CLPABP knockdown experiment using siRNA
s, and the expression levels of β-actin are shown as a control (middle lane).
ondrial morphology. HeLa cells were transfected with siRNA for CLPABP.
nel) and with Mito-Tracker (lower) are shown. Cells with reduced CLPABP
PABP expression on apoptosis. The induction of apoptosis in COS-7 cells due to
re shown in the left panel; Hoechst 33342 (center panel) was used to stain the
FP-CLPABP251-611 as a control (white) and GFP-CLPABP (black). (J) Co-
with the expression vector encoding GFP-CLPABP (a). The cells were processed
echest33342 was used to stain the nucleus (c). Merged images of the panels are
1046 E. Sano et al. / Biochimica et Biophysica Acta 1783 (2008) 1036–1047and determine its position for localization depending on the
amount of CL present on the surface of the mitochondrial outer
membrane.
In this study, we investigated many common components of
major RNA granules such as the stress granule [12] or the P-
body [13]. Although the relevance of eachmolecule in the role of
the CLPABP complex is unclear, it is interesting that the
complex contains cytochrome c mRNA. Kawai et al. have de-
monstrated that HuR binds to the 3′-UTR sequence of cyto-
chrome cmRNA to control mRNA stabilization and translation.
In addition to the SR-family proteins, the CLPABP complex also
contains HuR and hnRNPA1, which are also known as nuclear
shuttling proteins [36,37]. Therefore, the CLPABP complexmay
play a role in carrying cytochrome cmRNA to the mitochondria
via HuR.
The translational process involving ribosomal subunits may
be active in the CLPABP-RNA granule as compared to the
stress granule or the P-body. The CLPABP granule was partially
colocalized at the ER; many ribosomal proteins were included
in the CLPABP complex, and the granule was successfully
stained with the anti-cytochrome c antibody due to cytochrome
c production therein. Furthermore, the apoptosome that is
known to be an oligomer of cytochrome c and Apaf-1 was
generated, and apoptosis occurred in the cells that overex-
pressed CLPABP.
Cytochrome c is crucial for mitochondrial metabolism and
apoptotic events and therefore should be effectively translo-
cated into the mitochondria following the translational process
in the cytoplasm. We propose that CLPABP may play a role in
this translocation by forming a novel type of RNA granule that
carries the cytochrome c mRNA to the mitochondria, which
facilitates the mitochondrial recruitment of the polypeptide of
cytochrome c. Here, GFP-CLPABP could be transported along
the tubulin network, and endogenous CLPABP was colocalized
with mitochondria in the neuronal tubule of NGF-stimulated
PC12 cells (data not shown). Therefore, CLPABP may function
to transport cytochrome c mRNA into neurons along with
kinesin motor proteins [38].
In contrast to the conventional types of RNA granules, some
proteins in the CLPABP-RNA granule were identified as func-
tional molecules responsible for the specific localization of
mRNAwithin cells. Zip-code-binding protein (ZBP) 1, a human
IGF-II mRNA-binding protein (IMP) orthologue, functions in
carrying the β-actin mRNA to appropriate sites within the
vertebrate cells [39]; this process is regulated by tyrosine
phosphorylation [40]. Similarly, tyrosine-phosphorylated
CLPABP may function to transport the mRNA of mitochon-
drial-specific proteins; DNA microarray analysis is necessary in
order to detect the entire spectrum of mRNA transported by the
CLPABP complex.
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